Resultados de Búsqueda
There is no evidence that rapid diagnostic techniques for SARS-CoV-2 infection (antigens and molecular tests) in primary care or hospital care have the same precision as in specialized laboratories.
Evidencias COVID-19
Cochrane Portugal - Institute for Evidenced Based Health
The systematic review includes 22 studies of moderate quality, with a high risk of bias in 50% of the studies. It is concluded that there is no evidence that rapid diagnosis techniques for SARS-CoV-2 infection in primary or hospital care, which include screening tests and confirmatory studies of infection (by RT-PCR and clinical picture) have the same precision as in specialized laboratories.
ver más ... 2020It is recommendedental the health Interventions for college students during the COVID-19 Pandemic
Evidencias COVID-19
Unidad de Evidencia y Deliberación para la Toma de Decisiones, Facultad de Medicina - Universidad de
68 articles and 99 web resources were consulted. After reviewing the full text, 12 scientific articles and 11 web resources were included. With which it was concluded that it is beneficial to carry out structured and revised programs, promotion and prevention of mental health, attention to symptoms, pedagogical adaptations.
ver más ... 2020There is no evidence that the use of convalescent plasma as a treatment in hospitalized COVID-19 patients reduces the risk of disease progression or mortality.
Evidencias COVID-19
Fundación Cardioinfantil - Cochrane Colombia
The available evidence does not allow to define whether the use of convalescent plasma as part of the treatment of hospitalized patients for COVID-19 can reduce the risk of disease progression or mortality, so its use should be limited to experimental studies. The initiation time, dose and duration of treatment to achieve higher levels of antibodies in recipient patients with COVID-19 have not been established. The impact of this intervention as a prophylaxis in people at risk or as a treatment ...
ver más ... 2020There is no strong evidence of rapid site-of-care antigen and molecular testing for the diagnosis of SARS ‐ CoV ‐ 2 infection
Evidencias COVID-19
Cochrane - Revisión sistemática
Treatment Identifies early stage testing for SARS ‐ CoV ‐ 2 infection. The findings currently have limited applicability, as there is no certainty that tests are performed in the same way in clinical practice, or based on COVID-19 symptoms, duration of symptoms, or in asymptomatic people. Rapid tests allow earlier detection of those who test positive. However, the current evidence is not strong enough to determine its usefulness in clinical practice.
ver más ... 2020it is recommended the use of moisturizers and protective creams, alone or in combination, in the primary prevention of occupational irritant dermatitis.
Evidencias COVID-19
Evidence Aid
In this review, there are 9 trials included (2888 participants) and also identified 2 ongoing studies and 1 additional article that is pending assessment. The results of protective creams, moisturizers, a combination of both protective and moisturizing creams, or education on skin protection showed imprecise effects that favored the intervention.
ver más ... 2020